Cargando…

Complete and long-lasting response to immunotherapy: A case report of urothelial cancer

INTRODUCTION: Bladder cancer is the tenth most common cancer worldwide, with Europe having the highest incidence rates. Regarding the treatment of metastatic disease, first-line treatment for fit patients is cisplatin-containing combination chemotherapy. However, a significant percentage of patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva, Diogo J., Mesquita, Alexandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276433/ https://www.ncbi.nlm.nih.gov/pubmed/35713423 http://dx.doi.org/10.1097/MD.0000000000028940

Ejemplares similares

Clinical relevance of receptor conversion in metastatic breast cancer: Case report
por: Silva, Diogo J., et al.
Publicado: (2022)

Rectal mixed adenoneuroendocrine carcinoma: Case report
por: Silva, Diogo J., et al.
Publicado: (2021)

Long lasting complete response with immunotherapy in a metastatic bladder carcinoma: a case report
por: Magalhães, Denise S.T., et al.
Publicado: (2021)

Response to immunotherapy in a patient with anaplastic thyroid cancer: A case report
por: Zheng, Luming, et al.
Publicado: (2021)

Hyperprogression on immunotherapy with complete response to chemotherapy in a NSCLC patient with high PD-L1 and STK11: A case report
por: Fricke, Jeremy, et al.
Publicado: (2020)

Pseudoprogression in the era of immunotherapy-based strategies for recurrent head and neck squamous cell carcinoma achieving complete response: A case report
por: Zhou, Jiawei, et al.
Publicado: (2023)

Remarkable response to anti-PD1 immunotherapy in refractory metastatic high-grade myxofibrosarcoma patient: A case report
por: Luo, Yi, et al.
Publicado: (2021)

Complete response of radioresistant brain metastases from non-small cell lung cancer with temozolomide: A case report and literature review
por: Yang, Yi, et al.
Publicado: (2020)

Substantial tumor regression in prostate cancer patient with extensive skeletal metastases upon Immunotherapy (APCEDEN): A case report
por: Sharan, Bandana, et al.
Publicado: (2020)

Case report: pathological complete response in an IIIB non-small cell lung cancer patient after preoperative neoadjuvant nivolumab therapy combined with chemotherapy
por: Li, Luzhen, et al.
Publicado: (2022)

Primary pulmonary lymphoepithelioma-like carcinoma: A case report of pathological complete response (pCR) by neoadjuvant treatment
por: Zhang, Liqin, et al.
Publicado: (2021)

Identification of cancer-associated fibroblasts signature for predicting the prognosis and immunotherapy response in hepatocellular carcinoma
por: Ye, Jianzhong, et al.
Publicado: (2023)

Impressive long-term response with chemo-endocrine therapy in a premenopausal patient with metastatic breast cancer: A case report
por: Maltoni, Roberta, et al.
Publicado: (2020)

Iodine-125 radioactive particles antagonize hyperprogressive disease following immunotherapy: A case report
por: Yang, Ning, et al.
Publicado: (2020)

Successful chemotherapy with continuous immunotherapy for primary pulmonary endovascular epithelioid hemangioendothelioma: A case report
por: Guo, Wenliang, et al.
Publicado: (2023)

Durable response to immunotherapy plus chemotherapy in a patient with untreated, brain-metastatic, EGFR exon 20 insertion mutation lung adenocarcinoma: A case report
por: Nong, Jingying, et al.
Publicado: (2021)

Next generation sequencing predicting clinical effect of immunotherapy on adult rhabdomyosarcoma patient: A case report
por: Sun, Xiaogang, et al.
Publicado: (2023)

Long-term response with low-dose of apatinib combined with S-1 in pretreated patient with advanced squamous cell lung cancer: A case report
por: Chen, Jianxin, et al.
Publicado: (2021)

Immunotherapy-related pneumonitis and bacterial pneumonia after the successful treatment of metastatic malignant melanoma with pembrolizumab: A case report
por: Ma, Qin, et al.
Publicado: (2021)

Gastric cancer burden of last 40 years in North China (Hebei Province): A population-based study
por: Liang, Di, et al.
Publicado: (2017)

A prognostic signature associated with cell senescence predicts survival outcomes and strongly associates with immunotherapy and chemotherapy response in breast cancer
por: Pan, Tao, et al.
Publicado: (2023)

Predictors of Pathologic Complete Response in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation
por: Han, Yoon Dae, et al.
Publicado: (2015)

Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma
por: Huang, Qianrong, et al.
Publicado: (2023)

Partial response of donafenib as the third-line therapy in metastatic colon cancer: A case report
por: Yang, Yang, et al.
Publicado: (2021)

The safety and efficacy of chemotherapy combined with immunotherapy for pancreatic cancer: A meta-analysis
por: Huang, Yang, et al.
Publicado: (2021)

Knowledge mapping of immunotherapy for thyroid cancer from 1980 to 2022: A review
por: Ding, Ran, et al.
Publicado: (2023)

Liver Metastasis of a Triple-Negative Breast Cancer and Complete Remission for 5 Years After Treatment With Combined Bevacizumab/Paclitaxel/Carboplatin: Case Report and Review of the Literature
por: Ogata, Hideaki, et al.
Publicado: (2015)

Bibliometric and visualized analysis of the top-100 highly cited articles on immunotherapy for endometrial cancer
por: Zheng, Wanzhen, et al.
Publicado: (2023)

Argon plasma coagulation with atezolizumab and chemoradiation in lung pleomorphic cancer showed a remarkable response: Case report
por: Harada, Masanori, et al.
Publicado: (2021)

Long-term survival after sporadic and delayed metastases of conventional osteosarcoma: A case report
por: Kubo, Tadahiko, et al.
Publicado: (2017)

Long-term disease control by trabectedin in a patient with dedifferentiated liposarcoma: A case report
por: Matsuda, Shogo, et al.
Publicado: (2020)

Response to toripalimab combined with radiotherapy in advanced non-small cell lung cancer-not otherwise specified: A case report
por: Jin, Yonglong, et al.
Publicado: (2021)

Multimodal and systemic therapy with cabozantinib for treatment of recurrent hepatocellular carcinoma after liver transplantation: A case report with long term follow-up outcomes
por: Mahn, Robert, et al.
Publicado: (2021)

The role of stereotactic body radiation therapy in oligometastatic colorectal cancer: Clinical case report of a long-responder patient treated with regorafenib beyond progression
por: Roberto, Michela, et al.
Publicado: (2017)

Necrosis on pre-radiotherapy (18)F-FDG PET/CT is a predictor for complete metabolic response in patients with non-small cell lung cancer
por: Eren, Gülnihan, et al.
Publicado: (2022)

Pathologic complete response to neoadjuvant anti-HER2 therapy is associated with HER2 immunohistochemistry score in HER2-positive early breast cancer
por: Chen, Hai-long, et al.
Publicado: (2021)

Small Cell Lung Cancer Accompanied by Tonsillar Metastasis and Anti-Hu Antibody-Associated Paraneoplastic Neuropathy: A Rare Case Report With Long-Term Survival
por: Ni, Jianjiao, et al.
Publicado: (2015)

Lingual alveolar soft part sarcoma responsive to pazopanib: A case report
por: Yoshihiro, Tomoyasu, et al.
Publicado: (2017)

Long-term survival of advanced lung adenocarcinoma by maintenance chemotherapy followed by EGFR-TKI: A case report
por: Chen, Hui Jun, et al.
Publicado: (2021)

Case report of periorbital metastasis from rectal cancer
por: Paik, Jin-Hee, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qabsellmb5adsk9qnjnq701u0f